Safety of mifepristone abortions in clinical use.

[1]  B. Winikoff,et al.  Multicenter Trial of a Simplified Mifepristone Medical Abortion Regimen , 2005, Obstetrics and gynecology.

[2]  B. Winikoff,et al.  Infection after medical abortion: a review of the literature. , 2004, Contraception.

[3]  P. Stubblefield,et al.  Methods for induced abortion. , 2004, Obstetrics and gynecology.

[4]  Angela Y. Chen,et al.  A Randomized Comparison of Misoprostol 6 to 8 Hours Versus 24 Hours After Mifepristone for Abortion , 2004, Obstetrics and gynecology.

[5]  C. Berg,et al.  Risk Factors for Legal Induced Abortion–Related Mortality in the United States , 2004, Obstetrics and gynecology.

[6]  L. Prine,et al.  Medical abortion in family practice: a case series. , 2003, The Journal of the American Board of Family Practice.

[7]  R. Hausknecht.  Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States. , 2003, Contraception.

[8]  L. Meyn,et al.  Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion. , 2003, American journal of obstetrics and gynecology.

[9]  Jeani Chang,et al.  Pregnancy-Related Mortality Surveillance — United States , 1991 – 1999 , 2003 .

[10]  D. Blouin,et al.  Toxic shock syndrome due to Clostridium sordellii: a dramatic postpartum and postabortion disease. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  S. Fielding,et al.  Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy. , 2002, Contraception.

[12]  H. Helland,et al.  Early pregnancy termination with mifepristone and misoprostol in Norway , 2001, Acta obstetricia et gynecologica Scandinavica.

[13]  S. Fielding,et al.  Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. , 2001, Contraception.

[14]  S. Fielding,et al.  Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial. , 2000, JAMA.

[15]  C. Berg,et al.  Abortion surveillance--United States, 1999. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[16]  G. Penney,et al.  An effective regimen for early medical abortion: a report of 2000 consecutive cases. , 1998, Human reproduction.

[17]  C. Bardin,et al.  Early pregnancy termination with mifepristone and misoprostol in the United States. , 1998, The New England journal of medicine.

[18]  P. Franks,et al.  Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. , 1997, The Journal of family practice.

[19]  I. Sivin,et al.  Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. , 1997, American journal of obstetrics and gynecology.

[20]  A. Templeton,et al.  Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. , 1995, The New England journal of medicine.

[21]  E. Baulieu,et al.  Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol , 1993, The New England journal of medicine.

[22]  L. Finer,et al.  The accessibility of abortion services in the United States, 2001. , 2003, Perspectives on sexual and reproductive health.

[23]  S. Fielding,et al.  Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. , 2000, Contraception.

[24]  P. Franks,et al.  Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. , 1999, Contraception.